ArticleCureus2025
Thrombosis Despite Sub-Nephrotic Proteinuria.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While nephrotic syndrome is a recognized hypercoagulable state associated with an elevated risk of venous thromboembolism (VTE), sub-nephrotic proteinuria and resultant hypoalbuminemia have also been associated with a similar increased risk. We report on a 40-year-old patient who initially presented with findings of anasarca and dyspnea and was found to have bilateral lower extremity deep vein thromboses (DVTs) and pulmonary embolism on further testing. In pursuit of a kidney biopsy, the patient's anticoagulation was briefly held, which resulted in the development of new bilateral upper extremity DVTs. Our findings outline the need to consider the increased risk for VTE in patients with sub-nephrotic proteinuria and hypoalbuminuria, as the latter finding may be more indicative of clotting risk in this patient population. A multidisciplinary approach is needed to determine the optimal management strategy for these patients, especially when pursuing procedures requiring temporary discontinuation of pharmacological anticoagulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.